$TGTX
TG THERAPEUTICS, INC. Stock $tgtx

$tgtx Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-K Financial Statement

#000114420414014207 Filed on March 07, 2014

Income Statement

Concept	2014 Q1	2013	2012 Q4
Revenue	$38.10K	$152.4K	$20.00K
YoY Change	0.0%	699.98%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.230M	$6.660M	$1.530M
YoY Change	48.17%	39.33%	-52.78%
% of Gross Profit
Research & Development	$4.410M	$13.66M	$1.080M
YoY Change	180.9%	-35.03%	-614.29%
% of Gross Profit
Depreciation & Amortization	$706.00	$1.127K	$0.00
YoY Change	513.91%	379.57%
% of Gross Profit
Operating Expenses	$7.643M	$23.12M	$2.610M
YoY Change	103.7%	-14.1%	-13.58%
Operating Profit	-$7.605M	-$22.97M
YoY Change	104.77%	-14.61%
Interest Expense	$226.3K	$952.9K	$520.0K
YoY Change	-2.22%	5.21%	-71.74%
% of Operating Profit
Other Income/Expense, Net	$57.88K	$2.488M	$0.00
YoY Change	43.15%	138.72%
Pretax Income	-$7.547M	-$20.48M	-$3.170M
YoY Change	105.44%	-20.79%	166.39%
Income Tax	$0.00	$0.00	$330.0K
% Of Pretax Income
Net Earnings	-$7.547M	-$20.48M	-$3.460M
YoY Change	105.44%	13.31%	200.87%
Net Earnings / Revenue	-19811.65%	-13438.82%	-17300.0%
Basic Earnings Per Share
Diluted Earnings Per Share	-$250.9K	-$806.0K	-$174.7K
COMMON SHARES
Basic Shares Outstanding	34.37M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q1	2013	2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$53.50M	$40.50M	$16.50M
YoY Change	251.97%	145.45%	70.1%
Cash & Equivalents	$49.60M	$600.0K	$16.46M
Short-Term Investments	$3.900M
Other Short-Term Assets	$2.800M	$1.700M	$29.13K
YoY Change	7.69%	-15.0%	-70.87%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$56.30M	$42.30M	$18.48M
YoY Change	216.29%	128.65%	88.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$0.00	$0.00	$1.164K
YoY Change
Goodwill	$799.4K		$799.4K
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.000M	$4.900M
YoY Change
Other Assets	$76.42K	$100.0K	$0.00
YoY Change
Total Long-Term Assets	$1.874M	$5.800M	$3.598M
YoY Change	-47.95%	61.11%	-23.44%
TOTAL ASSETS
Total Short-Term Assets	$56.30M	$42.30M	$18.48M
Total Long-Term Assets	$1.874M	$5.800M	$3.598M
Total Assets	$58.17M	$48.10M	$22.07M
YoY Change	171.84%	117.65%	52.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.600M	$4.800M	$1.100M
YoY Change	14.29%	336.36%	57.14%
Accrued Expenses	$200.0K	$700.0K	$300.0K
YoY Change	-33.33%	133.33%	200.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$700.0K	$700.0K
YoY Change	-100.0%	0.0%	-22.22%
Total Short-Term Liabilities	$1.989M	$6.300M	$2.216M
YoY Change	-20.45%	186.36%	38.5%
LONG-TERM LIABILITIES
Long-Term Debt	$100.0K	$100.0K	$2.500M
YoY Change	-95.83%	-96.0%	-24.24%
Other Long-Term Liabilities	$1.600M	$1.700M	$1.800M
YoY Change	-11.11%	-5.56%
Total Long-Term Liabilities	$1.700M	$1.800M	$4.300M
YoY Change	-59.52%	-58.14%	30.3%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.989M	$6.300M	$2.216M
Total Long-Term Liabilities	$1.700M	$1.800M	$4.300M
Total Liabilities	$3.742M	$8.100M	$6.524M
YoY Change	-44.14%	24.62%	33.14%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$37.53K		$25.82K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$234.3K		$84.54K
YoY Change
Treasury Stock Shares	41.31K shares		13.53K shares
Shareholders Equity	$54.40M	$40.10M	$15.60M
YoY Change
Total Liabilities & Shareholders Equity	$58.17M	$48.10M	$22.07M
YoY Change	171.84%	117.65%	52.23%

Cashflow Statement

Concept	2014 Q1	2013	2012 Q4
OPERATING ACTIVITIES
Net Income	-$7.547M	-$20.48M	-$3.460M
YoY Change	105.44%	13.31%	200.87%
Depreciation, Depletion And Amortization	$706.00	$1.127K	$0.00
YoY Change	513.91%	379.57%
Cash From Operating Activities	-$8.330M	-$10.74M	-$840.0K
YoY Change	278.64%	106.94%	1300.0%
INVESTING ACTIVITIES
Capital Expenditures	$3.165K	$5.681K	$0.00
YoY Change		306.08%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$4.920M	$0.00
YoY Change			-100.0%
Cash From Investing Activities	$0.00	-$4.930M	$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	-$18.10M	-$37.50M
YoY Change		-44456.95%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	17.44M	39.69M	-80.00K
YoY Change	1755.32%	233.53%	-100.82%
NET CHANGE
Cash From Operating Activities	-8.330M	-10.74M	-840.0K
Cash From Investing Activities	0.000	-4.930M	0.000
Cash From Financing Activities	17.44M	39.69M	-80.00K
Net Change In Cash	9.110M	24.02M	-920.0K
YoY Change	-823.02%	257.97%	-109.45%
FREE CASH FLOW
Cash From Operating Activities	-$8.330M	-$10.74M	-$840.0K
Capital Expenditures	$3.165K	$5.681K	$0.00
Free Cash Flow	-$8.333M	-$10.75M	-$840.0K
YoY Change	278.78%	106.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q4	us-gaap	Liabilities Liabilities	6523736	USD
CY2012Q4	us-gaap	Goodwill Goodwill	799391	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	USD
CY2012Q4	us-gaap	Assets Assets	22074037	USD
CY2012Q4	tgtx	Prepaid Research And Development PrepaidResearchAndDevelopment	1990759	USD
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	29128	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	18475882	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5718	USD
CY2012Q4	us-gaap	Notes Payable Current NotesPayableCurrent	677778	USD
CY2012Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	145000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	152381	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	47804	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	42303263	USD
CY2013Q4	us-gaap	Goodwill Goodwill	799391	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	85121	USD
CY2013Q4	us-gaap	Assets Assets	48112390	USD
CY2013Q4	us-gaap	Notes Payable Current NotesPayableCurrent	677778	USD
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1828571	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	25821	USD
CY2012Q4	tgtx	Contingently Issuable Shares ContingentlyIssuableShares	6	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34534805	USD
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	84538	USD
CY2012Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	18925793	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15550301	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22074037	USD
CY2013	tgtx	Warrant Or Right Expired Weighted Average Exercise Price WarrantOrRightExpiredWeightedAverageExercisePrice	16.26
CY2012Q4	tgtx	Warrant Or Right Outstanding Weighted Average Exercise Price WarrantOrRightOutstandingWeightedAverageExercisePrice	1.58
CY2011Q4	tgtx	Warrant Or Right Aggregate Intrinsic Value WarrantOrRightAggregateIntrinsicValue	0	USD
CY2013	tgtx	Warrant Or Right Issued Weighted Average Exercise Price WarrantOrRightIssuedWeightedAverageExercisePrice	0
CY2012	tgtx	Warrant Or Right Exercised Weighted Average Exercise Price WarrantOrRightExercisedWeightedAverageExercisePrice	0
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	152381	USD
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	190017	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6317178	USD
CY2013Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1676191	USD
CY2013Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	64529	USD
CY2013Q4	us-gaap	Liabilities Liabilities	8057898	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16455995	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40485466	USD
CY2013Q4	tgtx	Prepaid Research And Development PrepaidResearchAndDevelopment	1742824	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1164	USD
CY2012Q4	tgtx	In Process Research And Development InProcessResearchAndDevelopment	2797600	USD
CY2013Q4	tgtx	In Process Research And Development InProcessResearchAndDevelopment	0	USD
CY2012Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	1117397	USD
CY2013Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	4764502	USD
CY2013Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	532500	USD
CY2012Q4	us-gaap	Interest Payable Current InterestPayableCurrent	123511	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2216067	USD
CY2012Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	2479098	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10746837	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10618584	shares
CY2013	tgtx	Period Anticipated Sufficient To Fund Operating Cash Flow PeriodAnticipatedSufficientToFundOperatingCashFlow	P24M
CY2012Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	2479098	USD
CY2013Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	64529	USD
CY2012Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	2479098	USD
CY2013Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	64529	USD
CY2012Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6781007	shares
CY2011Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3294797	USD
CY2012	tgtx	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Interest Accrued Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityInterestAccruedIncludedInEarnings	844173	USD
CY2013	tgtx	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Interest Accrued Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityInterestAccruedIncludedInEarnings	886382	USD
CY2012	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-1659872	USD
CY2013	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-3300951	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2479098	USD
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	64529	USD
CY2012Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.05	pure
CY2013Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.05	pure
CY2011Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	16876000	USD
CY2012Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	17727000	USD
CY2013Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	18614000	USD
CY2011Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	3287700	USD
CY2012	us-gaap	Fair Value Inputs Discount Rate FairValueInputsDiscountRate	0.2	pure
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3379	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	46000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2012	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2475	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	313	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	46904	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	46591	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	9591	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	9591	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1315.62
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.40
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	720.45
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2249.85
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	61.08
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	46.37
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	208.30
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	208.30
CY2012	tgtx	Shares Based Compensation Arrangement By Shares Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P9Y5M8D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y1M28D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y1M28D
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	USD
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2011Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1625911	shares
CY2012	tgtx	Warrant Or Right Issued WarrantOrRightIssued	5156599	shares
CY2013	tgtx	Warrant Or Right Issued WarrantOrRightIssued	0	shares
CY2012	tgtx	Warrant Or Right Exercised WarrantOrRightExercised	0	shares
CY2013	tgtx	Warrant Or Right Exercised WarrantOrRightExercised	1018068	shares
CY2012	tgtx	Warrant Or Right Expired WarrantOrRightExpired	1503	shares
CY2013	tgtx	Warrant Or Right Expired WarrantOrRightExpired	43992	shares
	us-gaap	Licenses Revenue LicensesRevenue	171429	USD
CY2013	tgtx	Non Cash Stock Expense NonCashStockExpense	0	USD
	tgtx	Non Cash Stock Expense NonCashStockExpense	16875000	USD
	tgtx	Non Cash Compensation Research And Development Expenses NonCashCompensationResearchAndDevelopmentExpenses	1497328	USD
CY2013	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	12621161	USD
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	16645626	USD
CY2013Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5718947	shares
CY2011Q4	tgtx	Warrant Or Right Outstanding Weighted Average Exercise Price WarrantOrRightOutstandingWeightedAverageExercisePrice	5.27
CY2012	tgtx	Warrant Or Right Issued Weighted Average Exercise Price WarrantOrRightIssuedWeightedAverageExercisePrice	1.21
CY2013	tgtx	Warrant Or Right Exercised Weighted Average Exercise Price WarrantOrRightExercisedWeightedAverageExercisePrice	2.25
CY2012	tgtx	Warrant Or Right Expired Weighted Average Exercise Price WarrantOrRightExpiredWeightedAverageExercisePrice	2739.75
CY2013Q4	tgtx	Warrant Or Right Outstanding Weighted Average Exercise Price WarrantOrRightOutstandingWeightedAverageExercisePrice	1.34
CY2012Q4	tgtx	Warrant Or Right Aggregate Intrinsic Value WarrantOrRightAggregateIntrinsicValue	14563539	USD
CY2013Q4	tgtx	Warrant Or Right Aggregate Intrinsic Value WarrantOrRightAggregateIntrinsicValue	14809030	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	3422182	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	5203148	USD
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	7977072	USD
CY2013Q4	tgtx	Share Based Compensation Non Employee Stock Options Outstanding ShareBasedCompensationNonEmployeeStockOptionsOutstanding	37000	shares
CY2013	tgtx	Stock Issued During Period Shares New Issues Shelf Registration Statement StockIssuedDuringPeriodSharesNewIssuesShelfRegistrationStatement	135000000	USD
CY2012Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	695428	shares
CY2013Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5700000	shares
CY2013Q3	us-gaap	Share Price SharePrice	6.15
CY2013Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	35000000	USD
CY2013Q3	tgtx	Stock Issued During Period Shares New Issues Overallotments StockIssuedDuringPeriodSharesNewIssuesOverallotments	855000	shares
CY2013Q3	tgtx	Net Proceeds From Shares New Issues Overallotments NetProceedsFromSharesNewIssuesOverallotments	37.6	USD
CY2013Q3	tgtx	Underwriting Discounts And Offering Expenses UnderwritingDiscountsAndOfferingExpenses	2700000	USD
CY2012Q4	us-gaap	Notes Payable NotesPayable	3156876	USD
CY2013Q4	us-gaap	Notes Payable NotesPayable	742307	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25820738	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34336235	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25807212	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34294926	shares
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	13526	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	41309	shares
CY2012Q4	us-gaap	Deferred Revenue DeferredRevenue	1981000	USD
CY2013Q4	us-gaap	Deferred Revenue DeferredRevenue	1829000	USD
CY2013	tgtx	Additional Amount Receivable On Achievement Of Pre Specified Milestones AdditionalAmountReceivableOnAchievementOfPreSpecifiedMilestones	5000000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	330000	USD
CY2012	us-gaap	Licenses Revenue LicensesRevenue	19048	USD
CY2013	us-gaap	Licenses Revenue LicensesRevenue	152381	USD
CY2012	tgtx	Non Cash Stock Expense NonCashStockExpense	16578000	USD
CY2012	tgtx	Non Cash Compensation Research And Development Expenses NonCashCompensationResearchAndDevelopmentExpenses	455809	USD
CY2013	tgtx	Non Cash Compensation Research And Development Expenses NonCashCompensationResearchAndDevelopmentExpenses	1041519	USD
CY2012	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	3994182	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21027991	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13662680	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	35017954	USD
CY2012	tgtx	Non Cash Compensation General And Administrative Expenses NonCashCompensationGeneralAndAdministrativeExpenses	2966373	USD
CY2013	tgtx	Non Cash Compensation General And Administrative Expenses NonCashCompensationGeneralAndAdministrativeExpenses	4161629	USD
	tgtx	Non Cash Compensation General And Administrative Expenses NonCashCompensationGeneralAndAdministrativeExpenses	7214496	USD
CY2012	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1815083	USD
CY2013	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2496461	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	46282857	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	4779741	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4781456	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6658090	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11994237	USD
CY2012	tgtx	Impairment Of In Process Research And Development ImpairmentOfInProcessResearchAndDevelopment	1104700	USD
CY2013	tgtx	Impairment Of In Process Research And Development ImpairmentOfInProcessResearchAndDevelopment	2797600	USD
	tgtx	Impairment Of In Process Research And Development ImpairmentOfInProcessResearchAndDevelopment	3902300	USD
CY2012	us-gaap	Operating Expenses OperatingExpenses	26914147	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	23118370	USD
	us-gaap	Operating Expenses OperatingExpenses	50914491	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-26895099	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-22965989	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-50743062	USD
CY2012	us-gaap	Investment Income Net InvestmentIncomeNet	15787	USD
CY2013	us-gaap	Investment Income Net InvestmentIncomeNet	30822	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	46609	USD
CY2012	us-gaap	Other Income OtherIncome	272232	USD
CY2013	us-gaap	Other Income OtherIncome	108894	USD
	us-gaap	Other Income OtherIncome	381126	USD
CY2012	us-gaap	Interest Expense InterestExpense	905744	USD
CY2013	us-gaap	Interest Expense InterestExpense	952888	USD
	us-gaap	Interest Expense InterestExpense	1865729	USD
CY2012	tgtx	Change In Fair Value Of Non Current Note Payable ChangeInFairValueOfNonCurrentNotePayable	1659872	USD
CY2013	tgtx	Change In Fair Value Of Non Current Note Payable ChangeInFairValueOfNonCurrentNotePayable	3300951	USD
	tgtx	Change In Fair Value Of Non Current Note Payable ChangeInFairValueOfNonCurrentNotePayable	4960823	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1042147	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2487779	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3522829	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-25852952	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-20478210	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-47220233	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	330000	USD
CY2012	us-gaap	Profit Loss ProfitLoss	-26182952	USD
CY2013	us-gaap	Profit Loss ProfitLoss	-20478210	USD
	us-gaap	Profit Loss ProfitLoss	-47550233	USD
CY2012	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8110233	USD
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8146230	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-18072719	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-20478210	USD
	us-gaap	Net Income Loss NetIncomeLoss	-39404003	USD
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.38
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.81
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13113758	shares
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	25413964	shares
CY2013	tgtx	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	2280773	USD
CY2013	tgtx	Stock Issued During Period Value Exercise Of Warrants Cash Less StockIssuedDuringPeriodValueExerciseOfWarrantsCashLess	-1	USD
CY2011	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1150	USD
CY2012	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2013	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9655816	USD
CY2012	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12181406	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	37648280	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	86494	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	188509	USD
CY2012	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1932710	USD
CY2013	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-229258	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1699859	USD
CY2012	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	USD
CY2013	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	85121	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	85121	USD
CY2012	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	595757	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	5203148	USD
CY2011	us-gaap	Profit Loss ProfitLoss	-889071	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9636202	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	2664970	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8711824	USD
CY2012	tgtx	Shares Issued In Connection With In Licensing Agreement SharesIssuedInConnectionWithInLicensingAgreement	16578000	USD
CY2013	tgtx	Shares Issued In Connection With In Licensing Agreement SharesIssuedInConnectionWithInLicensingAgreement	0	USD
	tgtx	Shares Issued In Connection With In Licensing Agreement SharesIssuedInConnectionWithInLicensingAgreement	16875000	USD
CY2012	us-gaap	Depreciation Depreciation	235	USD
CY2013	us-gaap	Depreciation Depreciation	1127	USD
	us-gaap	Depreciation Depreciation	1362	USD
CY2012	tgtx	Change In Fair Value Of Notes Payable ChangeInFairValueOfNotesPayable	815699	USD
CY2013	tgtx	Change In Fair Value Of Notes Payable ChangeInFairValueOfNotesPayable	2414569	USD
	tgtx	Change In Fair Value Of Notes Payable ChangeInFairValueOfNotesPayable	3230268	USD
CY2013	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	4034605	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	5038672	USD
CY2012	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	61571	USD
CY2013	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	66506	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	135174	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1980952	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-152381	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1828571	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-5187964	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-10824231	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-16098772	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1399	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5681	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7080	USD
CY2012	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2013	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	10386	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1399	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-4925552	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-4916565	USD
CY2012	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2013	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2280773	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2280773	USD
CY2012	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	200001	USD
CY2013	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	200001	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	37648280	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	47472962	USD
CY2012	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	12257309	USD
CY2013	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	12257309	USD
CY2012	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	75903	USD
CY2013	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	75903	USD
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	84538	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	149799	USD
CY2012	tgtx	Conversion Of Notes Payable To Preferred Stock ConversionOfNotesPayableToPreferredStock	0	USD
CY2013	tgtx	Conversion Of Notes Payable To Preferred Stock ConversionOfNotesPayableToPreferredStock	0	USD
	tgtx	Conversion Of Notes Payable To Preferred Stock ConversionOfNotesPayableToPreferredStock	55271	USD
CY2012	tgtx	Accrued Financing Costs AccruedFinancingCosts	0	USD
CY2013	tgtx	Accrued Financing Costs AccruedFinancingCosts	0	USD
	tgtx	Accrued Financing Costs AccruedFinancingCosts	61138	USD
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	234337	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	11896867	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	39779254	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	61500803	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6707504	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	24029471	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	40485466	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9748491	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Cash Cash	15955988	USD
CY2013Q4	us-gaap	Cash Cash	39931397	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2012	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1758001	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-917810	USD
CY2012	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	75000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	32190080	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	32399879	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1882238	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2266167	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	3051920	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	10971912	USD
CY2012Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-1202556	USD
CY2013Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	330000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	0	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	19241	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	644899	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	36270923	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	46282857	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	36270923	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	250000	USD
CY2012	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	230643	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	43026	USD
CY2012	tgtx	Effective Income Tax Reconciliation Foreign With Holding Tax EffectiveIncomeTaxReconciliationForeignWithHoldingTax	330000	USD
CY2013	tgtx	Effective Income Tax Reconciliation Foreign With Holding Tax EffectiveIncomeTaxReconciliationForeignWithHoldingTax	0	USD
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	10392361	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	10011934	USD
CY2011Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.15	pure
CY2011Q4	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.13	pure
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Trading Symbol TradingSymbol	TGTX
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	34373925	shares
CY2013	dei	Entity Registrant Name EntityRegistrantName	TG THERAPEUTICS, INC.
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001001316
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q2	dei	Entity Public Float EntityPublicFloat	74983321	USD
CY2011Q4	tgtx	Business Acquisition Shares Repurchased Percentage BusinessAcquisitionSharesRepurchasedPercentage	0.95	pure
CY2011Q4	tgtx	Fair Value Per Share Issued FairValuePerShareIssued	2.25
CY2012Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	13908560	USD
CY2011Q4	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	11091425	USD
CY2012Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1545396	shares
CY2011Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1232381	shares
CY2013Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2777962	shares
CY2012Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	2.25
CY2011Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	2.25
CY2013Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	2.25
CY2012Q2	tgtx	Class Of Warrant Or Rights Exercisable Period ClassOfWarrantOrRightsExercisablePeriod	P5Y
CY2011Q4	tgtx	Class Of Warrant Or Rights Exercisable Period ClassOfWarrantOrRightsExercisablePeriod	P5Y
CY2013Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	8.89	shares
CY2012Q1	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	20.00
CY2013Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	45431532	USD
CY2012Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	0	USD
CY2013Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	27169	USD
CY2012Q4	us-gaap	Long Term Investments LongTermInvestments	0	USD
CY2013Q4	us-gaap	Long Term Investments LongTermInvestments	4918897	USD
CY2013	tgtx	Cash Equivalents Maturity Period CashEquivalentsMaturityPeriod	less than three months
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">USE OF ESTIMATES</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the applicable reporting period. Actual results could differ from those estimates. Such differences could be material to the financial statements.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2012Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	ratio of 56.25 for 1
CY2012	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	0	USD
CY2013	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	27169	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	27169	USD
CY2012	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
CY2013	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	4919871	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	4919871	USD
CY2012Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	500007	USD
CY2013Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	554069	USD
CY2011	tgtx	Common Stock Issued During Period Value To Founders In Exchange For Seed Capital CommonStockIssuedDuringPeriodValueToFoundersInExchangeForSeedCapital	106578	USD
CY2011	tgtx	Common Stock Issued During Period Value In Exchange For License Option CommonStockIssuedDuringPeriodValueInExchangeForLicenseOption	297000	USD
CY2011	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	322964	USD
CY2011	tgtx	Stock Issued During Period Value Conversion Of Note Payable To Preferred Stock StockIssuedDuringPeriodValueConversionOfNotePayableToPreferredStock	55271	USD
CY2011Q2	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	7000000	USD
CY2011	tgtx	Stock Issued During Period Value Of Replacement Restricted Preferred Stock To Employees StockIssuedDuringPeriodValueOfReplacementRestrictedPreferredStockToEmployees	0	USD
CY2012	tgtx	Shares Issued To Non Controlling Interest In Connection With Licensing Agreement SharesIssuedToNonControllingInterestInConnectionWithLicensingAgreement	16578000	USD
CY2013	tgtx	Potential Future Milestone Payments PotentialFutureMilestonePayments	182500000	USD
CY2012	tgtx	Upfront Fee Received From Sub License UpfrontFeeReceivedFromSubLicense	2000000	USD
CY2012	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2012	tgtx	Non Controlling Interest Subsidiary Shares Value NonControllingInterestSubsidiarySharesValue	0	USD
CY2012	tgtx	Treasury Stock Value During Peirod TreasuryStockValueDuringPeirod	-84538	USD
CY2013	tgtx	Treasury Stock Value During Peirod TreasuryStockValueDuringPeirod	-149799	USD
CY2012	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1104700	USD
CY2013	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2797600	USD
CY2012	us-gaap	Income Tax Expense Benefit Continuing Operations Discontinued Operations Extraordinary Items IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems	-8790003	USD
CY2013	us-gaap	Income Tax Expense Benefit Continuing Operations Discontinued Operations Extraordinary Items IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems	-6962592	USD
CY2013Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	4918897	USD
CY2013	us-gaap	Held To Maturity Securities Unrecognized Holding Gains HeldToMaturitySecuritiesUnrecognizedHoldingGains	0	USD
CY2013	us-gaap	Held To Maturity Securities Unrecognized Holding Losses HeldToMaturitySecuritiesUnrecognizedHoldingLosses	650	USD
CY2013Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	4918247	USD
CY2012	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	0	USD
CY2013	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	975	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	975	USD
CY2012	tgtx	Income Tax Reconciliation Change Incontingent Note Payable IncomeTaxReconciliationChangeIncontingentNotePayable	0	USD
CY2013	tgtx	Income Tax Reconciliation Change Incontingent Note Payable IncomeTaxReconciliationChangeIncontingentNotePayable	-1924558	USD

Files In Submission

Name	View Source	Status
0001144204-14-014207-index-headers.html	Edgar Link	pending
0001144204-14-014207-index.html	Edgar Link	pending
0001144204-14-014207.txt	Edgar Link	pending
0001144204-14-014207-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
ft0001img-4.jpg	Edgar Link	pending
ft0001img-5.jpg	Edgar Link	pending
ft0001img-6.jpg	Edgar Link	pending
ft0001img-7.jpg	Edgar Link	pending
ft0001img-8.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tgtx-20131231.xml	Edgar Link	completed
tgtx-20131231.xsd	Edgar Link	pending
tgtx-20131231_cal.xml	Edgar Link	unprocessable
tgtx-20131231_def.xml	Edgar Link	unprocessable
tgtx-20131231_lab.xml	Edgar Link	unprocessable
tgtx-20131231_pre.xml	Edgar Link	unprocessable
v369569_10k.htm	Edgar Link	pending
v369569_ex23-1.htm	Edgar Link	pending
v369569_ex31-1.htm	Edgar Link	pending
v369569_ex31-2.htm	Edgar Link	pending
v369569_ex32-1.htm	Edgar Link	pending
v369569_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TGTX
TG THERAPEUTICS, INC. Stock $tgtx

2014 Q1 Form 10-K Financial Statement

#000114420414014207 Filed on March 07, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TGTX TG THERAPEUTICS, INC. Stock $tgtx

2014 Q1 Form 10-K Financial Statement

#000114420414014207 Filed on March 07, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TGTX
TG THERAPEUTICS, INC. Stock $tgtx